NCT07641569 Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease
| NCT ID | NCT07641569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saglik Bilimleri Universitesi |
| Condition | Parkinson's Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 39 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 39 participants in total. It began in 2026-06-15 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are: \- Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence. Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training. Participants will: * Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks. * Participate in assessments at the study clinic before and after exercise training.
Eligibility Criteria
Inclusion Criteria: * Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria. * Being in stages 1-3 according to the Hoehn-Yahr Scale. Exclusion Criteria: * Presence of a neurological disease other than Parkinson's disease * Cognitive impairment (Standardized Mini Mental Test score less than 24) * Having undergone deep brain stimulation surgery * Having a visual, auditory, or perceptual problem * Having any orthopedic, rheumatological, or other condition that may affect walking and balance.
Frequently Asked Questions
Who can join the NCT07641569 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07641569 currently recruiting?
Yes, NCT07641569 is actively recruiting participants. Visit ClinicalTrials.gov or contact Saglik Bilimleri Universitesi to inquire about joining.
Where is the NCT07641569 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07641569 clinical trial?
NCT07641569 is sponsored by Saglik Bilimleri Universitesi. The trial plans to enroll 39 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.